Mechanistically, loss of co-stimulatory signals like HVEM/CD28 could impair antigen presentation of new tumor antigens generated by high TMB, while the immune-suppressive microenvironment mediated by B7-H3 may counterbalance the immune recognition advantage from genomic instability. The gene discussed is CD276; the disease is neoplasm.